Connective Tissue Growth Factor belongs to the CCN family of proteins. The CCN family presently consists of six members in human also known as: Cyr61 (Cystein rich 61), CTGF (Connective Tissue Growth Factor), Nov (Nephroblastoma Overexpressed gene), WISP-1, 2 and 3 (Wnt-1 Induced Secreted Proteins). The CCN genes encode secreted proteins associated with the Extracellular Matrix (ECM) and cell membrane. CCN proteins are matricellular proteins which are involved in the regulation of various cellular functions including: proliferation, differentiation, survival, adhesion and migration. They are expressed in derivatives of the three embryonic sheets and are implicated in the development of kidney, nervous system, muscle, bone marrow, cartilage and bone. During adulthood, they are implicated in wound healing, bone fracture repair, and pathologies such as: fibrosis, vascular ailments and tumorigenesis. Full length secreted CCN proteins can show an antiproliferative activity, whereas truncated isoforms are likely to stimulate proliferation and behave as oncogenes. The full length protein consists of four modules: Module I shares partial identity with the N-terminal part of the Insulin-like Growth Factor Binding Proteins (IGFBPs). Module II includes a stretch of 70aa residues - which shares sequence identity with the Von Willebrand Factor Type C repeat (VWC). Module III contains sequences sharing identity with the Thrombospondin type 1 repeat (TSP1) (WSXCSXXCG), which is thought to be implicated in the binding of sulfated glycoconjugates and to be important for cell adhesion. Module IV, also designated CT, is encoded by exon5. It is the leasts conserved one of the four domains at the level of nucleotide sequence, but it appears to be critical for several of the biological functions attributed to the CCN proteins. Module IV resembles the CT domain of several extracellular protein including, Von Willebrand's factor and mucins. Sequence similarities to heparin-binding motifs are also found within this domain. Proteolysis of the secreted full-length CCN proteins that has been reported in the case of CCN2 and CCN3 might result in the production of CCN-derived peptides with high affinity for ligands that full-length CNN proteins bind only poorly. Amino-truncated CCN2 isoforms were biologically active whereas no specific biological activity has been attributed to the truncated CCN3. Although the molecular processes underlying the production of these secreted isoforms is presently unknown, it is important to note that proteolysis occur at the same amino acid residues in both CCN2 and CCN3. An elevated expression of CCN2 has also been detected by Northern blotting in human invasive mammary ductal carcinomas, dermatofibromas, pyogenic granuloma, endothelial cells of angiolipomas and angioleiomyomas, and in pancreatic tumors. A study performed with chondrosarcomas representative of various histological grades established that CCN2 expression was closely correlated with increasing levels of malignancy. In agreement with CCN2 playing a role in brain tumor angiogenesis, immunocytochemistry studies indicated that both glioblastoma tumor cells and proliferating endothelial cells stained positive for CCN2. In astrocytomas, CCN2 expression was particularly elevated in high grade tumors, with a marked effect of CCN2 on cell proliferation. Downregulation of CCN2 expression in these cells was associated with a growth arrest at the G1/S transition while over-expression of CCN2 induced a two-fold increase of the number of cells in the G1 phase. Gene profiling analysis allowed to identify a set of about 50 genes whose expression might account for the proliferative activity of CCN2 in these cells. CCN2 was seen in a higher proportion of mononuclear cells of patients with acute lymphoblastic leukemia.||Source:|Recombinant protein corresponding to human CTGF, a single, non-glycosylated, polypeptide chain containing 98aa, expressed in E. coli. ||Molecular Weight: |~11.2kD||Biological Activity:|Determined by the dose-dependent stimulation of the proliferation of HUVEC cells. The expected ED50 for this effect is 1-2ug/ml. ||AA Sequence:|MGKKCIRTPK ISKPIKFELS GCTSMKTYRA KFCGVCTDGR CCTPHRTTTL PVEFKCPDGE VMKKNMMFIK TCACHYNCPG DNDIFESLYY RKMYGDMA ||Storage and Stability:|Lyophilized powder may be stored at -20°C. Stable for 12 months after receipt at -20°C. Reconstitute with sterile buffer. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.Source: E. coli |Purity: ~95% (SDS-PAGE)|Concentration: ~0.1mg/ml (after reconstitution)|Form: Supplied as a lyophilized powder in 10mM sodium acetate buffer, pH 6.0. Reconstitute with 100ug/ml 5mM sodium acetate, pH 6.0.||Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. 2018年8月，蚂蚁淘成为UnitedStatesBiological（简称USBio）代理商，UnitedStatesBiological也简称为USBiological。 欢迎广大客户咨询订货，在线QQ：3507623898 4000-520-616 最主要的一抗产品： 144747-FITC Anti-IL-6(BCellstimulatoryfactor2)(FITC) Pab rabbit human IgG Hu FITC $592 IL6 WB 100ul 144764-FITC Anti-Interferongamma(IFN-gamma)(FITC) Pab rabbit rat IgG Rt FITC $592 IFNG E,IHC,IP,N,WB 100ul 144739-FITC Anti-IL-3(Hematopoieticgrowthfactor,Mastcellgrowthfactor)(FITC) Pab rabbit human IgG Hu FITC $592 IL3 E,IHC,IP,N,WB 100ul 144964-FITC Anti-NFKB1(KBF1,NF-kappaB,NFkappaB,NF-kB1,NFKB-p50,EBP-1,p50,p105,TRANSCRIPTIONFACTORNFKB1,DNA-bindingfactorKBF1,NFKBp50,INCLUDED,NFKBp105,INCLUDED,NuclearfactorofkappalightpolypeptidegeneenhancerinBCells1)(FITC) Pab rabbit human IgG Hu,Mo,Rt FITC $628 NFKB1 WB 100ul 303092-FITC Anti-ACE(ACE1,ACET,ACE_HUMAN,ACE1,AngiotensinConvertingEnzymeSomaticIsoform,AngiotensinConvertingEnzymeTestisSpecificIsoform,AngiotensinIConvertingEnzyme,AngiotensinIConvertingEnzyme1,AngiotensinIConvertingEnzymePeptidylDipeptidaseA1,Angiotensin-convertingEnzyme,Carboxycathepsin,CD143,CD143,CD143Antigen,DCP1,DCP,DCP1,DipeptidylCarboxypeptidase1,DipeptidylCarboxypeptidaseI,KininaseII,MVCD3,PeptidaseP,PeptidylDipeptidaseA,SolubleForm,TesticularECA)(FITC) Pab rabbit human IgG Hu,Mo,Rt FITC $592 IHC,WB 100ul 145142-FITC Anti-SCF(Mastcellgrowthfactor)(FITC) Pab rabbit human IgG Hu FITC $592 KITLG E,WB 100ul 145147-FITC Anti-SDHA(FlavoproteinsubunitofcomplexII)(FITC) Pab rabbit human IgG Hu,Mo,Rt FITC $628 SDHA IHC,WB 100ul 145286-FITC Anti-TNC(Hxb,Hexabrachion,Tenascin-C,TN-C,TN,CYTOTACTIN,hexabrachion(tenascinC,cytotactin),hexabrachion(tenascin),MGC167029)(FITC) Pab rabbit human IgG Hu,Mo,Rt FITC $628 TNC IHC,WB 100ul 303394-FITC Anti-Interleukin1Beta(IL1beta,Catabolin,H1,Hematopoietin1,IFNbetaInducingFactor,IL1,IL1beta,IL1B,IL-1beta,IL1Beta,IL1B,IL1B_HUMAN,IL1F2,Interleukin1betaPrecursor,Interleukin-1beta,LAF,OAF,OsteoclastActivatingFactor,Preinterleukin1beta,Preinterleukinbeta,ProInterleukin1beta)(FITC) Pab rabbit rat IgG Rt FITC $592 E,WB 100ul 303592-FITC Anti-SerumAmyloidP(9.5Salpha1Glycoprotein,9.5Salpha-1-glycoprotein,AmyloidPComponentSerum,APCS,PentaxinRelated,Pentraxin2,PTX2,PTX2,SAMP_HUMAN,SAP,SerumAmyloidPComponent,SerumAmyloidP-component(1-203))(FITC) Pab rabbit rat IgG Rt FITC $592 IHC,WB 100ul 144120-HRP Anti-Actin(Gamma-actin)(HRP) Pab rabbit human IgG Hu,Mo,Rt HRP $628 ACTG1 IHC,WB 100ul 144129-HRP Anti-ADAMTS2(ProcollagenIN-proteinase)(HRP) Pab rabbit human IgG Hu,Rt HRP $628 ADAMTS2 IHC,WB 100ul 144160-HRP Anti-ANGPTL3(ANG-5,ANGPT5,Angiopoietin-5)(HRP) Pab rabbit human IgG Hu,Mo,Rt HRP $628 ANGPTL3 WB 100ul 144183-HRP Anti-ApoptosisregulatorBcl-2(HRP) Pab rabbit human IgG Hu HRP $592 BCL2 E,IP,N,WB 100ul 144190-HRP Anti-AQP3(Aquaglyceroporin-3)(HRP) Pab rabbit human IgG Hu,Mo,Rt HRP $628 AQP3 IC,IHC,WB 100ul